Substance / Medication

Para-aminobenzoic acid

Overview

Active Ingredient
4-aminobenzoic acid
RxNorm CUI
74

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Binding Isotope Effects for para-Aminobenzoic Acid with Dihydropteroate Synthase from Staphylococcus aureus and Plasmodium falciparum.
Stratton Christopher F, Namanja-Magliano Hilda A, Cameron Scott A et al. · ACS Chem Biol · 2015
PMID: 26288086ObservationalFull text (PMC)
Effects of para-aminobenzoic acid (PABA) form and administration mode on PABA recovery in 24-hour urine collections.
Sharma Rashmi S, Joy Raechel C, Boushey Carol J et al. · J Acad Nutr Diet · 2014
PMID: 24183994Observational
Rapid and sensitive HPLC assay for simultaneous determination of procaine and para-aminobenzoic acid from human and rat liver tissue extracts.
Dhananjeyan Mugunthu R, Trendel Jill A, Bykowski Crystal et al. · J Chromatogr B Analyt Technol Biomed Life Sci · 2008
PMID: 18450526Observational
Free and total para-aminobenzoic acid analysis in plants with high-performance liquid chromatography/tandem mass spectrometry.
Zhang Guo-Fang, Mortier Kjell A, Storozhenko Sergei et al. · Rapid Commun Mass Spectrom · 2005
PMID: 15759312Observational
A prospective, comparative study of the para-aminobenzoic acid test and faecal elastase 1 in the assessment of exocrine pancreatic function.
Sonwalkar S A, Holbrook I B, Phillips I et al. · Aliment Pharmacol Ther · 2003
PMID: 12562462Observational
Identification of N-Hydroxy-para-aminobenzoic acid in a cyanotic child after benzocaine exposure.
Spiller H A, Russell J L, Casavant M J et al. · Clin Toxicol (Phila) · 2014
PMID: 25211007Case Report
Enhanced assessment of water quality for both nitrate and nitrite using engineered E. coli with para-aminobenzoic acid biosynthesis.
Wang Tsun-To, Yuan Chia-Ching, Lu Yung-Kang et al. · Anal Chim Acta · 2025
PMID: 39832852Other
Enhancement of optical limiting activity of para-aminobenzoic acid using silver nanoparticles.
Lakhera Shradha, Rana Meenakshi, Dhuliya Vivek et al. · Sci Rep · 2025
PMID: 40849347OtherFull text (PMC)
Combinatorial engineering pinpoints shikimate pathway bottlenecks in para-aminobenzoic acid production in Pseudomonas putida.
Campos-Magaña Marco A, Moreno-Paz Sara, Martin-Pascual Maria et al. · J Biol Eng · 2025
PMID: 41029715OtherFull text (PMC)
Dietary para-aminobenzoic acid, uric acid, and antibiotics modulate the susceptibility ofandto.
Costa Breno A, Godoy Raquel S M, Henrique-Gomes Lucas et al. · Front Cell Infect Microbiol · 2025
PMID: 41409545PreclinicalFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Para-aminobenzoic acid (substance)
SNOMED CT
373489001
UMLS CUI
C0000473
RxNorm CUI
74

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.